Pfizer's Japan Growth Nears Point It Could Challenge Takeda Dominance
This article was originally published in PharmAsia News
Executive Summary
Pfizer Japan has expanded its local business to the extent it could challenge Takeda Pharmaceutical as the nation's largest drug maker, if the latest earnings report is any indication.